FY2025 · period end Dec '25 · from the 10-K filed Feb 18, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $20.32B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001690820-26-000039 | May 5, 2026 | May 6, 2026 | May 6, 2026 20:48 UTC | EDGAR |
| 8-K | 0001690820-26-000034 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 20:05 UTC | EDGAR |
| 10-Q | 0001690820-26-000035 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 20:11 UTC | EDGAR |
| 8-K | 0001690820-26-000008 | Feb 18, 2026 | Feb 18, 2026 | Feb 18, 2026 21:05 UTC | EDGAR |
| 10-K | 0001690820-26-000009 | Dec 31, 2025 | Feb 18, 2026 | Feb 18, 2026 21:11 UTC | EDGAR |
| 8-K | 0001690820-25-000352 | Oct 29, 2025 | Oct 29, 2025 | Oct 29, 2025 20:06 UTC | EDGAR |
| 10-Q | 0001690820-25-000353 | Sep 30, 2025 | Oct 29, 2025 | Oct 29, 2025 20:11 UTC | EDGAR |
| 8-K | 0001690820-25-000310 | Jul 30, 2025 | Jul 30, 2025 | Jul 30, 2025 20:06 UTC | EDGAR |
Direct links to SEC EDGAR. CVNA has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Income (Loss) Available to Common Stockholders, Basic·Q2 2017
Major restatementwas-$4.3M
Revised down in a 10-Q.
Long-term Debt and Lease Obligation·As of Dec 31, 2018
Major restatementwas$425.3M
Revised down in a 10-Q.
Net Income (Loss) Available to Common Stockholders, Diluted·FY 2023
Major restatementwas$450M
Revised down in a 10-K.
Net Income (Loss) Attributable to Parent·Q2 2019
Major restatementwas-$26.6M
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·Q3 2019
Major restatementwas-$39M
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·3 months to Dec 2018
Major restatementwas-$28.7M
Revised up in a 10-K.
CVNA is not the only one.
See every restatement we've found across the market — or get an alert the next time CVNA revises a number.
Restatements are detected by comparing every vintage of a fact across all of CARVANA CO.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CVNA's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling CARVANA CO. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CVNA yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CVNA and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $10.77B |
| $13.60B |
| $12.81B |
| Gross Profit | $4.19B | $2.88B | $1.72B | $1.25B | $1.93B |
|---|
| Operating Income | $1.88B | $0.99B | negative: -$0.08B | negative: -$2.35B | — |
|---|
| Net Income | $1.41B | $0.21B | $0.45B | negative: -$1.59B | negative: -$0.14B |
|---|
| EPS (Diluted) | $8.45 | $1.59 | $0.75 | negative: -$15.74 | negative: -$3.00 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $13.20B | $8.48B | $7.07B | $8.70B | $7.01B |
| Total Liabilities | $9.00B | $7.11B | $7.46B | $9.75B | $6.49B |
| Stockholders' Equity | $4.20B | $1.38B | negative: -$0.38B | negative: -$1.05B | $0.53B |
| Cash & Equivalents | $2.33B | $1.76B | $0.53B | $0.63B | $0.64B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.04B | $0.92B | $0.80B | negative: -$1.32B | negative: -$2.59B |
| Capital Expenditures | $0.15B | $0.09B | $0.09B | $0.51B | $0.56B |
| Free Cash Flow | $0.89B | $0.83B | $0.72B | negative: -$1.84B | negative: -$3.15B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 20.6% | 21.0% | 16.0% | 9.2% | 15.1% |
| Operating Margin | 0.1% | 0.1% | 0.0% | negative: -0.2% | negative: -0.0% |
| Net Margin | 0.1% | 0.0% | 0.0% | negative: -0.1% | negative: -0.0% |
| Return on Equity | 50.4% | 15.3% | negative: -117.2% | 150.7% | negative: -20.3% |
| Return on Assets | 13.0% | 2.7% | 5.7% | negative: -20.2% | negative: -2.7% |
| Debt / Equity | 1.22× | 4.04× | — | — | 10.21× |
